Company / Interest Expense per Share
Outlook Therapeutics, Inc. Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-$0.13
FY2025
5-year range
-$0.13 / $0.43
FY2021-FY2025
Trend
-209.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed -209% YoY in FY2025, a notable deviation from the 5-year average annual change of -16%.
Based on SEC 10-K filings.
-0.13 in FY2025.
Improved from $0.43 to $-0.13 over the past 6 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense per share decreased 209.0% year-over-year.
- Peak interest expense per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.13 | -209.0% |
| FY2020 | $0.12 | -71.9% |
| FY2019 | $0.43 | +91.0% |
| FY2018 | $0.23 | +177.8% |
| FY2017 | $0.08 | -66.6% |
| FY2016 | $0.24 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026